Averix Bio is a U.S.-based cannabinoid research and extraction company that specialises in producing cGMP Active Pharmaceutical Ingredients (API) compliant with 21 CFR Part 210 and Part 211 and ICH Q7 guidelines. The company is dedicated to offering an extensive range of high-quality phytocannabinoid CBD ingredients tailored for the pharmaceutical industry.

Services include:
– cGMP compliant cannabinoid extraction
– Research and development of cannabinoid formulations
– Custom manufacturing of phytocannabinoid APIs
– Quality control and assurance testing
– Regulatory support and compliance consulting

Averix Bio is committed to pioneering innovation in the cannabinoid space while adhering to the highest industry standards. For more information, please visit averixbio.com.